Stoke Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
17.92 |
181.14 |
24.72 |
47.29 |
94.90 |
216.30 |
| Przychód Δ r/r |
0.00% |
910.68% |
-86.35% |
91.32% |
100.66% |
127.93% |
| Przychód (min) |
15.74 |
45.00 |
24.58 |
39.07 |
78.40 |
178.71 |
| Przychód (max) |
18.82 |
495.03 |
24.86 |
63.48 |
127.39 |
290.36 |
| EBITDA (średnia) |
-3.58 |
-36.23 |
-4.94 |
-9.46 |
-18.98 |
-43.26 |
| EBIT (średnia) |
-3.58 |
-36.23 |
-4.94 |
-9.46 |
-18.98 |
-43.26 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-110.33 |
8.98 |
-177.29 |
-169.55 |
-81.28 |
-13.68 |
| Zysk netto % |
-615.61% |
4.96% |
-717.21% |
-358.51% |
-85.65% |
-6.33% |
| EPS (średnia) |
-2.02 |
0.17 |
-2.88 |
-2.50 |
-1.50 |
-0.25 |
| Liczba analityków (Przychody) |
8 |
7 |
10 |
8 |
6 |
7 |
| Liczba analityków (EPS) |
8 |
7 |
8 |
7 |
5 |
2 |
| symbol |
STOK |
STOK |
STOK |
STOK |
STOK |
STOK |